Depomed Comments on Horizon Pharma Announcement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Guggenheim Confident Horizon Pharma (HZNP) Can Get Depomed (DEPO) Deal Done; Sees 53% Upside Upon Closing
August 3, 2015 12:54 PM EDTGuggenheim analyst Louise Chen reiterated a Buy rating on Horizon Pharma (NASDAQ: HZNP) after the company announced two steps forward in its potential acquisition of Depomed (NASDAQ: DEPO): 1) Submitted a request to set a record date to determine SH's... More
Depomed (DEPO) to Review Horizon Pharma (HZNP) Request; Files Suit Over Improper Use of NUCYNTA Info
August 3, 2015 10:12 AM EDTDepomed (NASDAQ: DEPO) commented on Horizon Pharma plc's (NASDAQ: HZNP) ("Horizon") announcement that it intends to request that Depomed's Board of Directors ("Depomed Board") set a record date to determine the shareholders eligible to request a special meeting.
The Depomed Board will review the request when it is received. Provided that such request is received today and contains the information required under Depomed's bylaws, the Depomed Board will, no later than August 31, 2015, fix a record date to determine shareholders entitled to request a special meeting, as... More
